EUVIMEDEUVIMED entdecken
Open Access

Effect of Predeparture Testing on Postarrival SARS-CoV-2–Positive Test Results Among International Travelers — CDC Traveler-Based Genomic Surveillance Program, Four U.S. Airports, March–September 2022

Stephen M Bart, Teresa C Smith, Sarah Anne J Guagliardo, Allison Taylor Walker, Benjamin H Rome, Siyao Lisa Li, Thomas W S Aichele, Rob Stein, Ezra T Ernst, Robert C Morfino, Martin S Cetron, Cindy R Friedman

MMWR. Morbidity and Mortality Weekly Report · 2023

DOI: 10.15585/mmwr.mm7208a2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, 2023. Verfasst von Stephen M Bart und 11 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, Air Travel. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beginning December 6, 2021, all international air passengers boarding flights to the United States were required to show either a negative result from a SARS-CoV-2 viral test taken ≤1 day before departure or proof of recovery from COVID-19 within the preceding 90 days (1). As of June 12, 2022, predeparture testing was no longer mandatory but remained recommended by CDC (2,3). Various modeling studies have estimated that predeparture testing the day before or the day of air travel reduces transmission or importation of SARS-CoV-2 by 31%-76% (4-7). Postarrival SARS-CoV-2 pooled testing data from CDC's Traveler-based Genomic Surveillance program were used to compare SARS-CoV-2 test results among volunteer travelers arriving at four U.S. airports during two 12-week periods: March 20-June 11, 2022, when predeparture testing was required, and June 12-September 3, 2022, when predeparture testing was not required. In a multivariable logistic regression model, pooled nasal swab specimens collected during March 20-June 11 were 52% less likely to be positive for SARS-CoV-2 than were those collected during June 12-September 3, after adjusting for COVID-19 incidence in the flight's country of origin, sample pool size, and collection airport (adjusted odds ratio [aOR] = 0.48, 95% CI = 0.39-0.58) (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Air TravelHumansUnited StatesSARS-CoV-2AirportsGenomicsCenters for Disease Control and Prevention, U.S.

Zitieren

APA

Bart, S. M., Smith, T. C., Guagliardo, S. A. J., Walker, A. T., Rome, B. H., Li, S. L., Aichele, T. W. S., Stein, R., Ernst, E. T., Morfino, R. C., Cetron, M. S., & Friedman, C. R. (2023). Effect of Predeparture Testing on Postarrival SARS-CoV-2–Positive Test Results Among International Travelers — CDC Traveler-Based Genomic Surveillance Program, Four U.S. Airports, March–September 2022. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7208a2

Vancouver

Bart SM, Smith TC, Guagliardo SAJ, Walker AT, Rome BH, Li SL, et al. Effect of Predeparture Testing on Postarrival SARS-CoV-2–Positive Test Results Among International Travelers — CDC Traveler-Based Genomic Surveillance Program, Four U.S. Airports, March–September 2022. MMWR. Morbidity and Mortality Weekly Report. 2023. doi:10.15585/mmwr.mm7208a2

BibTeX
@article{Bart2023,
  author = {Bart, Stephen M and Smith, Teresa C and Guagliardo, Sarah Anne J and Walker, Allison Taylor and Rome, Benjamin H and Li, Siyao Lisa and Aichele, Thomas W S and Stein, Rob and Ernst, Ezra T and Morfino, Robert C and Cetron, Martin S and Friedman, Cindy R},
  title = {Effect of Predeparture Testing on Postarrival SARS-CoV-2–Positive Test Results Among International Travelers — CDC Traveler-Based Genomic Surveillance Program, Four U.S. Airports, March–September 2022},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2023},
  doi = {10.15585/mmwr.mm7208a2}
}
Kostenlos starten →